Search

You searched for "investigation"

504 results found

Improving on the Rotterdam Prostate Cancer Risk Calculator

1 January 2019 | | URO - Technology
Following the PROMIS trial [1], many cancer centres in the UK are now offering pre-biopsy multiparametric MRI (mpMRI) for men suitable for radical treatment. The European Association of Urology for Prostate Cancer (PCa) guidelines recommend individual risk stratification before the...

Software to keep you up to date

6 January 2023 | | URO - Technology
Scientific literature continues to expand exponentially, with an average doubling period of 15 years [1]. Staying up to date is an ever-increasing challenge and our time is constantly being consumed by attention-hungry social media platforms, slow NHS IT systems and...

Orchid: fighting male cancer for over 25 years

1 July 2022 | URO - Urologic Oncology
Orchid was established in 1996 by a young testicular cancer patient, Colin Osborne MBE, and the oncologist who saved his life, Professor Tim Oliver MD, FRCP. The charity exists to save men’s lives from testicular, penile, and prostate cancers and...

Managing sustainability

2 April 2024 |
Planetary health needs to be addressed at a societal level for any meaningful impact to occur. As the global director of sustainability for a law firm, Marion Palmer provides an overview of the responsibilities of corporate organisations for both a...

Erectile Dysfunction Part I: pathophysiology and risk factors

1 March 2014 | | URO - Andrology
Introduction Erectile dysfunction (ED) is defined as the inability to achieve and maintain a penile erection, which is adequate for satisfactory sexual intercourse. The Massachusetts Male Ageing Study (MMAS) reported the results of a regional survey of men aged 40–69...

#DontPayToStay Campaign – how one urology trainee led a successful campaign to eliminate charges for non-resident on call accommodation across England

1 September 2019 | | URO - Core Urology
The 2016 terms and conditions of service (junior doctor contract) introduced the following clause: 11. Where a doctor is rostered to work on a non-resident on-call working pattern and the doctor elects voluntarily, subject to the availability of accommodation, to...

Balanitis xerotica obliterans

1 September 2018 | | URO - Andrology, URO - Urologic Oncology
Balanitis xerotica obliterans (BXO) / lichen sclerosus of the male genitalia is a common cause of acquired phimosis, and was first described by Stuhmer in 1928 [1]. It is described in medical literature as a chronic inflammatory condition of unknown...

Bupa covers accurate PSE prostate cancer blood test

9 April 2025 | Contracts & Distributors, Research & Development
A new era in prostate cancer detection is emerging with the EpiSwitch® PSE blood test, a highly accurate tool that enhances early diagnosis while significantly cutting false positives. Now covered by Bupa as a pre-biopsy test, PSE has demonstrated 94%...

In conversation with Tamsin Greenwell

5 December 2024 | URO - Functional / Reconstructive Urology
We were delighted to chat with Tamsin Greenwell, Consultant Urological Surgeon at University College London Hospital and Chair of the United Kingdom Continence Society. Can you tell us a little bit about what attracted you to the field of urology...

Using cryopreserved prepubertal testis tissues – are we getting warmer?

12 September 2023 | | URO - Andrology, URO - Basic Science Research, URO - Urologic Oncology
The rising incidence of childhood cancer coupled with increasing survivorship means there is a growing population of childhood cancer survivors with unmet health needs. In the UK around 1 in 500 children and young people are survivors of childhood cancer....

Peyronie’s disease: a review and update

1 September 2017 | | URO - Andrology
Peyronie’s disease (PD) describes an acquired disease of the penis, which is characterised by a number of signs and symptoms. These include penile pain, curvature, palpable plaques, wasting or narrowing of the penile shaft, a hinge deformity and potentially catastrophic...

History of prostate biopsy – part 2

1 September 2018 | | URO - Basic Science Research, URO - Urologic Oncology, URO - Technology
For Part 1 of this topic is available here. The major limitations of the transrectal ultrasound (TRUS) guided prostate biopsy (PBx) protocols are the risk of profound sepsis and the risk of persistently significant false negative rates, related to the...